Log In
Print
BCIQ
Print
Print this Print this
 

Z123212, Z212

  Manage Alerts
Collapse Summary General Information
Company Zalicus Inc.
DescriptionSmall molecule that blocks the Nav1.7 (SCN9A) and Nav1.8 (PN3; SCN10A) sodium channels
Molecular Target Nav1.7 (SCN9A) ; Nav1.8 (PN3) (SCN10A)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today